The European Cobalt STent With Antiproliferative for Restenosis Trial (EuroSTAR Trial)

NCT00974181 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

282

Enrollment

INDUSTRY

Sponsor class

Conditions

Treatment of Symptomatic Ischemic Heart Disease

Interventions

DEVICE: Conor Medsystems COSTAR™ stent (10 µg Paclitaxel)
DEVICE: Conor Medsystems COSTAR™ stent (30 µg Paclitaxel)

Sponsor

Cordis US Corp.

Collaborators

[object Object]